NDC 0409-0830
Aztreonam
Aztreonam
Aztreonam is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Aztreonam.
| Product ID | 0409-0830_df6f3885-f4ab-4e41-a350-92a90709cf04 |
| NDC | 0409-0830 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Aztreonam |
| Generic Name | Aztreonam |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2022-01-24 |
| Marketing Category | ANDA / |
| Application Number | ANDA206517 |
| Labeler Name | Hospira, Inc. |
| Substance Name | AZTREONAM |
| Active Ingredient Strength | 2 g/1 |
| Pharm Classes | Monobactam Antibacterial [EPC], Monobactams [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |